Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
RG-6382 by F. Hoffmann-La Roche for Systemic Lupus Erythematosus: Likelihood of Approval
RG-6382 is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Systemic Lupus Erythematosus. According to...